Unit No:  [**Numeric Identifier 60026**]
Admission Date: [**2179-1-26**]
Discharge Date: [**2179-2-8**]
Date of Birth:  [**2104-9-8**]
Sex:  M
Service:  [**Last Name (un) **]


CHIEF COMPLAINT:  Esophageal dysplasia, high grade.

HISTORY OF PRESENT ILLNESS:  The patient is a 74-year-old
white male with a history of significant for high-grade
esophageal dysplasia who presented to [**Hospital6 649**] on [**2179-1-26**], for elective
thoracoscopic and laparoscopic esophagogastrectomy.

PAST MEDICAL HISTORY:  Hypertension.  Depression.

MEDICATIONS ON ADMISSION:  Hydrochlorothiazide 50 mg daily,
Atenolol 25 mg daily, Lipitor 10 mg daily, Fluoxetine 20 mg,
Prilosec, Multivitamin, Aspirin 81 mg once daily.

ALLERGIES:  None.

SOCIAL HISTORY:  The patient has a remote smoking history.
He quit in [**2138**].  He denied alcohol and recreational drug
use.

FAMILY HISTORY:  Noncontributory.

REVIEW OF SYMPTOMS:  He reports feeling well on the day of
surgery.  He denied recent fever, chills, nausea, vomiting,
shortness of breath, chest pain, or light-headedness.

PHYSICAL EXAMINATION:  Vital signs:  Temperature 97.9, heart
rate 80, blood pressure 168/89, respirations 12, oxygen
saturation 96 percent on room air.  General:  The patient was
alert and oriented.  He was comfortable.  HEENT:  Pupils
equal, round and reactive to light.  No scleral icterus.  No
jugular venous distension.  No lymphadenopathy.  No
thyromegaly.  Chest:  Clear to auscultation bilaterally.
Heart:  Regular, rate, and rhythm without murmur.  Abdomen:
Nondistended, soft, nontender to palpation.  Extremities:
Distal neurovascular intact.

HOSPITAL COURSE:  The patient presented to [**Hospital3 **]
[**Hospital **] [**First Name (Titles) **] [**Last Name (Titles) **] on [**2179-1-26**], for elective
laparoscopic and thoracoscopic esophagogastrectomy and
placement of a feeding jejunostomy tube for high-grade
esophageal dysplasia.  The patient underwent the procedure on
[**2179-1-26**].  The patient tolerated the procedure well.
After recovery in the Postanesthesia Care Unit, he was
transferred in stable condition to the Surgical Intensive
Care Unit intubated.

On postoperative day 1, he remained intubated and was in
stable condition.  He did require two fluid boluses for low
urine output.  On postoperative day 2, the patient continued
to remain clinically stable but intubated.  He continued to
be weaned from his vent, and on postoperative day 3, he
presented with a temperature spike for which blood cultures,
urine culture, and sputum culture were obtained.  He also
went into rapid atrial fibrillation and was promptly
converted to sinus rhythm with intravenous Lopressor, which
he would remain on.

He continued to be weaned from his vent and was extubated on
postoperative day 3, which he tolerated well.  He continued
on tube feeds, which were advanced to goal.

On postoperative day 4, he began to get out of bed with
Physical Therapy.  On postoperative day 5, he was transferred
to the floor in stable condition.  He underwent a swallow
study which was negative for leak.  His chest tube remained
draining serosanguineous fluid.

He was started on sips, which he tolerated well.  On
postoperative day 7, he was advanced to a clear-liquid diet,
which he tolerated well.  He continued to ambulate easily and
often.

On postoperative day 8, he was advanced to a regular diet,
which he tolerated well.  His chest tube was discontinued;
however, he did have a fever spike to 102 degrees.  Blood
cultures, urine culture, and chest x-ray were obtained.

Chest x-ray was suggestive for right middle lobe/right lower
lobe.  He was started on Zosyn.

On postoperative day 9, he was noted to have increased
erythema with exudate from around his [**Location (un) 1661**]-[**Location (un) 1662**] drain
site.  Vancomycin was started.  His neck incision was
partially opened but revealed no signs of infection at the
incision site.

He continued to remain stable and afebrile, tolerating a
regular diet, and ambulating often.  His Vancomycin and Zosyn
were discontinued on postoperative day 12.  On postoperative
day 12, his [**Location (un) 1661**]-[**Location (un) 1662**] drain from his neck was removed,
which he tolerated well.

On postoperative day 13, he was discharged to home in good
condition afebrile and vital signs within normal limits.  He
was ambulating easily.  He was given a seven-day supply of
Levaquin.

FOLLOW UP:  The patient is to follow-up with Dr. [**Last Name (STitle) **]
within the next few days after discharge.  He is to call Dr.[**Name (NI) 45689**] office at [**Telephone/Fax (1) 2981**] for a follow-up
appointment.

DISCHARGE MEDICATIONS:  Protonix 40 mg once daily, Percocet 1-
2 tab p.o. q.4-6 hours as needed, Ambien 5 mg p.o. q.h.s.,
Levaquin 500 mg p.o. daily x 7 days, Metoprolol 50 mg p.o.
t.i.d., Hydrochlorothiazide 25 mg p.o. once daily, Lipitor 10
mg p.o. once daily, Aspirin 81 mg p.o. once daily, Fluoxetine
20 mg p.o. once day, Multivitamin, Albuterol Ipratropium
inhaler as needed.

MAJOR SURGICAL/INVASIVE PROCEDURES:  Laparoscopic
thoracoscopic esophagogastrectomy with placement of a feeding
jejunostomy tube.

CONDITION ON DISCHARGE:  Good.

DISCHARGE INSTRUCTIONS:  The patient is to keep the wound
area clean and dry.  He is to take his medications as
prescribed.  He is to seek medical attention if he
experiences fevers, chills, nausea, vomiting, or increased
neck, chest, or abdominal pain.



                        [**First Name11 (Name Pattern1) 333**] [**Last Name (NamePattern4) 366**], [**MD Number(1) 367**]

Dictated By:[**Last Name (NamePattern1) 16264**]
MEDQUIST36
D:  [**2179-2-8**] 11:25:32
T:  [**2179-2-8**] 15:56:37
Job#:  [**Job Number **]



